Clinical Trials Browser

Phase 1 × Carcinoma, Renal Cell × Biological Products × Clear all

NCT03549000 2024-12-13

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Phase 1 Terminated

BreastGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT00014131 2023-10-04

Vaccine Therapy in Treating Patients With Kidney Cancer

Phase 1 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms